Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Novartis SWX:NOVN |
228,60 B | 3,02% | 5/6 | 1,27% | -29,61% | 5,63% | UP |
|
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SHSE:600276 |
372,21 B | 3,23% | 4/6 | 21,01% | 22,51% | 40,50% | DOWN |
|
Lantheus Holdings NasdaqGM:LNTH |
5,07 B | 45,37% | 5/6 | -10,57% | 18,59% | 8,86% | UP |
|
Telix Pharmaceuticals ASX:TLX |
4,60 B | 140,36% | 3/6 | 13,01% | 86,39% | 52,80% | DOWN |
